#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cortical dysplasia Epilepsy Cutaneous T-cell lymphoma recurrent Nephropathy Paroxysmal nocturnal haemoglobinuria Infantile spasms Breast angiosarcoma metastatic Hepatoblastoma B precursor type acute leukaemia Acute myeloid leukaemia refractory Medulloblastoma recurrent Adrenogenital syndrome Non-small cell lung cancer recurrent Diabetes insipidus Endometrial adenocarcinoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Basic Information Thrombotic thrombocytopenic purpura – Treatment Hereditary angioedema Myelodysplastic syndrome with excess blasts – Trials in Disease Angiosarcoma non-metastatic – Basic Information Sjogren’s syndrome – Diagnostics Von Willebrand’s disease – Diagnostics Idiopathic pulmonary fibrosis – Diagnostics Paroxysmal nocturnal haemoglobinuria – Treatment Atypical teratoid/rhabdoid tumour of CNS – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NALMEFENE HYDROCHLORIDE Lithium GSKVX000000030918 Iopromide Mannitol Taurine Tadekinig Alfa Ifosfamide CITRIC ACID ANHYDROUS Perflubutane Interferon Beta-1B Nortriptyline Hydrochloride Levocarnitine Pc14586 GS-4321 Mavorixafor Arachis Hypogaea Extract Lidocaine Fingolimod Hydrochloride Peginterferon Beta-1A More therapies…

    Learn about Your Condition

    Pharyngeal cancer stage II Hypercholesterolaemia Glioblastoma multiforme Neurodegenerative disorder Pharyngeal cancer stage I Tooth loss Hypotonia Catatonia Tachypnoea Connective tissue disorder Substance use disorder Angiosarcoma recurrent Type V hyperlipidaemia Intestinal infarction Angelman's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Bioequivalence study of ezetimibe and atorvastatin tablets versus film‑coated tablets in healthy volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Atorvastatin Calcium
    • Ezetimibe
    • Atorvastatin
    Spain

  • A study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    • Rituximab
    Belgium Denmark France Germany Poland Spain

  • Safety and Tolerability of REGN7999 in Healthy Adult Participants

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Iron overload
    Investigated Drugs:
    • REGN7999
    Belgium

  • Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Belgium Estonia Finland France Germany Italy +1

  • A study to evaluate how food affects the absorption of cytisinicline in healthy adult smokers

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cytisinicline
    Portugal

  • A study to compare how hydrochlorothiazide tablets work in healthy volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Hydrochlorothiazide
    Spain
Previous Page
1 … 921 922 923 924 925 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!